Stock Events

Stock Events

Roche 

€358.6
2059
-€0.6-0.17% Thursday 13:30

Statistics

Day High
359.2
Day Low
357.6
52W High
419
52W Low
292.6
Volume
0
Avg. Volume
3
Mkt Cap
0
P/E Ratio
-
Dividend Yield
3.02%
Dividend
10.83

Upcoming

12
MAR 27
Dividend Ex
Estimated
 
16
MAR 27
Dividend Payment
Estimated
 
13
MAR 28
Dividend Ex
Estimated
 
17
MAR 28
Dividend Payment
Estimated
 

Dividends

3.02%Dividend Yield
Mar 26
€1.1
Mar 26
€10.83
Mar 25
€10.19
Mar 24
€9.98
Mar 23
€9.63
10Y Growth
3.8%
5Y Growth
5.63%
3Y Growth
3.98%
1Y Growth
6.33%

Earnings

29JanExpected
Q2 2025
Q4 2025
8.83
9.85
10.86
11.88
Expected EPS
9.049057153472
Actual EPS
8.828734117

Financials

20.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
132.03BRevenue
27.64BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ROGH.VI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap214.76B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap160.66B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, the company supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. It has collaboration with Gilead Sciences, Inc. for COVID-19; and a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Show more...
CEO
ISIN
CH0012032113

Listings

MI
IT
1ROG.MI
MI
IT
1RO.MI
MX
MX
ROP1N.MX
XETRA
DE
RHO.XETRA

0 Comments

Share your thoughts

FAQ

What is Roche stock price today?▼
The current price of ROGH.VI is €358.6 EUR — it has decreased by -0.17% in the past 24 hours. Watch Roche stock price performance more closely on the chart.
What is Roche stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Roche stocks are traded under the ticker ROGH.VI.
When is the next Roche earnings date?▼
Roche is going to release the next earnings report on July 23, 2026.
What were Roche earnings last quarter?▼
ROGH.VI earnings for the last quarter are 8.83 EUR per share, whereas the estimation was 9.05 EUR resulting in a -2.43% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Roche revenue for the last year?▼
Roche revenue for the last year amounts to 132.03B EUR.
What is Roche net income for the last year?▼
ROGH.VI net income for the last year is 27.64B EUR.
Does Roche pay dividends?▼
Yes, ROGH.VI dividends are paid annual. The last dividend per share was 10.83 EUR. As of today, Dividend Yield (FWD)% is 3.02%.
When did Roche complete a stock split?▼
Roche has not had any recent stock splits.